Cargando…

The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma

The tumor microenvironment is a dynamic network of stromal, cancer, and immune cells that interact and compete for resources. We have previously identified the Vanin1 pathway as a tumor suppressor of sarcoma development via vitamin B5 and coenzyme A regeneration. Using an aggressive sarcoma cell lin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miallot, Richard, Millet, Virginie, Roger, Anais, Fenouil, Romain, Tardivel, Catherine, Martin, Jean-Charles, Shintu, Laetitia, Berchard, Paul, Sousa Lanza, Juliane, Malissen, Bernard, Henri, Sandrine, Ugolini, Sophie, Dutour, Aurélie, Finetti, Pascal, Bertucci, François, Blay, Jean-Yves, Galland, Franck, Naquet, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Life Science Alliance LLC 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583838/ https://www.ncbi.nlm.nih.gov/pubmed/37833072 http://dx.doi.org/10.26508/lsa.202302200

Ejemplares similares

Correction: The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma
por: Miallot, Richard, et al.
Publicado: (2023)

Metabolic landscapes in sarcomas
por: Miallot, Richard, et al.
Publicado: (2021)

An OMA1 redox site controls mitochondrial homeostasis, sarcoma growth, and immunogenicity
por: Miallot, Richard, et al.
Publicado: (2023)

Vnn1 pantetheinase limits the Warburg effect and sarcoma growth by rescuing mitochondrial activity
por: Giessner, Caroline, et al.
Publicado: (2018)

Effect of Pantethine on Ovarian Tumor Progression and Choline Metabolism
por: Penet, Marie-France, et al.
Publicado: (2016)

Radiotherapy in bone sarcoma: the quest for better treatment option
por: Locquet, Marie-Anaïs, et al.
Publicado: (2023)

Aldehyde Dehydrogenase, a Therapeutic Target in Chordoma: Analysis in 3D Cellular Models
por: Locquet, Marie-Anaïs, et al.
Publicado: (2021)

A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages
por: Richert, Iseulys, et al.
Publicado: (2023)

Natural Molecules and Neuroprotection: Kynurenic Acid, Pantethine and α-Lipoic Acid
por: Tóth, Fanni, et al.
Publicado: (2021)

Potential antiviral effects of pantethine against SARS-CoV-2
por: Abou-Hamdan, M., et al.
Publicado: (2023)

Sox17 Regulates Liver Lipid Metabolism and Adaptation to Fasting
por: Rommelaere, Samuel, et al.
Publicado: (2014)

Pantethine Down-Regulates Leukocyte Recruitment and Inflammatory Parameters in a Mouse Model of Allergic Airway Inflammation
por: Abou-Hamdan, Mhamad, et al.
Publicado: (2017)

Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor γ activity
por: Berruyer, Carole, et al.
Publicado: (2006)

Antioxidants selenomethionine and D-pantethine decrease the negative side effects of doxorubicin in NL/Ly lymphoma-bearing mice
por: Panchuk, Rostyslav R., et al.
Publicado: (2016)

Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer’s disease: Alleviation by pantethine
por: van Gijsel-Bonnello, Manuel, et al.
Publicado: (2017)

Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury
por: Cornille, Emilie, et al.
Publicado: (2010)

Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model
por: Brunetti, Dario, et al.
Publicado: (2014)

Correction: Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine
por: van Gijsel-Bonnello, Manuel, et al.
Publicado: (2018)

Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study
por: Chang, Xuting, et al.
Publicado: (2020)

Inhibition of Chondrosarcoma Growth by mTOR Inhibitor in an In Vivo Syngeneic Rat Model
por: Perez, Jennifer, et al.
Publicado: (2012)

PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target
por: Bertucci, François, et al.
Publicado: (2019)

The immune landscape of chondrosarcoma reveals an immunosuppressive environment in the dedifferentiated subtypes and exposes CSFR1+ macrophages as a promising therapeutic target
por: Iseulys, Richert, et al.
Publicado: (2019)

Proteomics, and Metabolomics: Magnetic Resonance Spectroscopy for the Presurgical Screening of Thyroid Nodules
por: Minuto, Michele N, et al.
Publicado: (2014)

CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response
por: Boudin, Laurys, et al.
Publicado: (2022)

Slow-spinning low-sideband HR-MAS NMR spectroscopy: delicate analysis of biological samples
por: Renault, Marie, et al.
Publicado: (2013)

snoRNAs Offer Novel Insight and Promising Perspectives for Lung Cancer Understanding and Management
por: Mourksi, Nour-El-Houda, et al.
Publicado: (2020)

Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins?
por: Aulas, Anaïs, et al.
Publicado: (2020)

Neuroimaging in Primary Coenzyme-Q(10)-Deficiency Disorders
por: Münch, Juliane, et al.
Publicado: (2023)

The Functional Landscape of Hsp27 Reveals New Cellular Processes such as DNA Repair and Alternative Splicing and Proposes Novel Anticancer Targets
por: Katsogiannou, Maria, et al.
Publicado: (2014)

The mystery of the (not) missing coenzyme
por: Short, Ben
Publicado: (2012)

Caspase-8 deficiency induces a switch from TLR3 induced apoptosis to lysosomal cell death in neuroblastoma
por: Locquet, Marie-Anaïs, et al.
Publicado: (2021)

Basal Breast Cancer: A Complex and Deadly Molecular Subtype
por: Bertucci, F, et al.
Publicado: (2012)

The E2F4 prognostic signature is also predictive of the pathological response of breast cancer to chemotherapy
por: Bertucci, François, et al.
Publicado: (2015)

XPO1, therapeutic … and prognostic target in sarcomas
por: Bertucci, François, et al.
Publicado: (2016)

Ribosome Biogenesis Alterations in Colorectal Cancer
por: Nait Slimane, Sophie, et al.
Publicado: (2020)

Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature
por: Bertucci, Francois, et al.
Publicado: (2022)

Causes of low muscle coenzyme-Q levels beyond primary coenzyme-Q-deficiency
por: Finsterer, Josef, et al.
Publicado: (2018)

Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
por: de Jong, Yvonne, et al.
Publicado: (2018)

Prediction of Early Breast Cancer Metastasis from DNA Microarray Data Using High-Dimensional Cox Regression Models
por: Zemmour, Christophe, et al.
Publicado: (2015)

The “great” controlling nucleotide coenzymes
por: Veech, Richard L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a241sdsfs9r3mf01kvb75pvu7n